Levofloxacin Noridem

Levofloxacin, the active ingredient in Levofloxacin Noridem, is a fluoroquinolone antibiotic presented as an injection for intravenous use. It treats bacterial infections such as community‑acquired pneumonia, hospital‑acquired pneumonia, complicated urinary tract infections, complicated intra‑abdominal infections, and skin and soft‑tissue infections in adult patients.

GNH USA supplies Levofloxacin Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat serious bacterial infections affecting various organ systems.

- Community‑acquired pneumonia: rapid bacterial eradication leading to clinical cure. - Hospital‑acquired pneumonia: effective against resistant pathogens in hospitalized patients. - Complicated urinary tract infections: clears infection in upper urinary tract and kidneys. - Complicated intra‑abdominal infections: eliminates mixed aerobic and anaerobic bacteria. - Skin and soft‑tissue infections: resolves cellulitis and other bacterial skin conditions.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis after antibiotic use. - Severe allergic reactions: anaphylaxis, angioedema. - Hepatic failure: rare but potentially life‑threatening liver injury. - Seizures: especially in patients with CNS disorders or concomitant pro‑convulsant drugs.

Levofloxacin requires careful patient assessment and monitoring to minimize risks.

- Renal function assessment: adjust dosing in patients with impaired kidney function. - Tendon monitoring: advise patients to report tendon pain or swelling promptly. - Hypersensitivity avoidance: do not use in individuals with known fluoroquinolone allergy. - QT‑prolongation caution: avoid in patients with existing cardiac conduction abnormalities. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with several drug classes, affecting safety or efficacy.

Major Interactions (Avoid): - Other fluoroquinolones: additive toxicity, especially tendon and CNS effects. - QT‑prolonging agents (e.g., macrolides, antiarrhythmics): increased risk of arrhythmias. - Warfarin: enhanced anticoagulant effect, may raise INR. - Antacids containing magnesium or aluminum: may reduce drug absorption (relevant for oral forms).

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of tendon rupture. - Diabetes agents (e.g., insulin, sulfonylureas): possible hypoglycemia. - Theophylline: increased plasma concentrations, risk of toxicity. - Cyclosporine: elevated levels may occur, requiring dose adjustment.